- Home
- PHGE vs CVR Comparison
PHGE vs CVR Comparison
Compare PHGE & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- CVR
- Stock Information
- Founded
- PHGE 2015
- CVR 1920
- Country
- PHGE Israel
- CVR United States
- Employees
- PHGE N/A
- CVR N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- PHGE Health Care
- CVR Industrials
- Exchange
- PHGE Nasdaq
- CVR Nasdaq
- Market Cap
- PHGE 10.4M
- CVR 11.1M
- IPO Year
- PHGE N/A
- CVR N/A
- Fundamental
- Price
- PHGE $0.52
- CVR $9.20
- Analyst Decision
- PHGE Strong Buy
- CVR
- Analyst Count
- PHGE 1
- CVR 0
- Target Price
- PHGE $15.00
- CVR N/A
- AVG Volume (30 Days)
- PHGE 991.6K
- CVR 1.5K
- Earning Date
- PHGE 08-13-2025
- CVR 08-08-2025
- Dividend Yield
- PHGE N/A
- CVR 1.30%
- EPS Growth
- PHGE N/A
- CVR N/A
- EPS
- PHGE N/A
- CVR N/A
- Revenue
- PHGE N/A
- CVR $25,617,681.00
- Revenue This Year
- PHGE N/A
- CVR N/A
- Revenue Next Year
- PHGE N/A
- CVR N/A
- P/E Ratio
- PHGE N/A
- CVR N/A
- Revenue Growth
- PHGE N/A
- CVR N/A
- 52 Week Low
- PHGE $0.34
- CVR $8.15
- 52 Week High
- PHGE $1.23
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- PHGE 50.56
- CVR 24.53
- Support Level
- PHGE $0.49
- CVR $9.38
- Resistance Level
- PHGE $0.56
- CVR $9.89
- Average True Range (ATR)
- PHGE 0.04
- CVR 0.29
- MACD
- PHGE -0.01
- CVR -0.15
- Stochastic Oscillator
- PHGE 49.28
- CVR 9.06
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.